[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370175-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370175-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","biological-characterization-and-clinical-significance-of-cuproptosis-related-genes-in-lung-adenocarcinoma","Biological characterization and clinical significance of cuproptosis-related genes in lung adenocarcinoma","","Lung adenocarcinoma presents high morbidity and mortality and often lacks early clinical manifestations, limiting surgical opportunities and leaving prognosis suboptimal. This study investigates biological characteristics and clinical relevance of cuproptosis-related genes in LUAD, aiming to clarify molecular events driving initiation and progression and to support discovery of diagnostic and prognostic biomarkers. Differential cuproptosis-associated genes were identified across GEO and TCGA datasets and then evaluated with computational analyses and immunohistochemistry validation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/biological-characterization-and-clinical-significance-of-cuproptosis-related-genes-in-lung-adenocarcinoma/370175/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/biological-characterization-and-clinical-significance-of-cuproptosis-related-genes-in-lung-adenocarcinoma/370175.png","ImageObject",300,407,{"name":42,"@type":43},"Logic","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main objective regarding cuproptosis in lung adenocarcinoma?","Question",{"text":63,"@type":64},"To examine the biological characteristics and clinical significance of cuproptosis-related genes in LUAD and to understand molecular mechanisms underlying LUAD occurrence and progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cuproptosis-related genes were highlighted as key LUAD differential genes?",{"text":68,"@type":64},"CDKN2A and MTF1 were identified as cuproptosis-associated LUAD differential genes with distinct differential expression across immune subtypes.",{"name":70,"@type":61,"acceptedAnswer":71},"How were the findings validated in the study?",{"text":72,"@type":64},"The study combined bioinformatics analyses using multiple databases and R/Cytoscape-related workflows, followed by immunohistochemistry validation to assess biological characteristics and clinical significance in LUAD.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370175,1790398005,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Li etal. BMC Pulmonary Medicine (2025) 25:13 [https://doi.org/10.1186/s12890-025-03477-4](https://doi.org/10.1186/s12890-025-03477-4)  \nBMC Pulmonary Medicine  \n RESEARCH Open Access  \nBiological characterization and clinical significance of cuproptosis-related genes in lung adenocarcinoma  \nMeilin Li 1†, Yu Tan2†, Zhixin Li3 and Lingfeng Min2*  \nAbstract  \nBackground Lung cancer has high morbidity and mortality rates, which results in a poor prognosis. Cuproptosisis a novel cell death mechanism. The aim of this study was to examine the biological characteristics and clinical significance of genes associated with cuproptosis in lung adenocarcinoma (LUAD), and to understand the molecular mechanisms underlying the occurrence and progression of LUAD.  \nMethods We targeted 10 cuproptosis-related genes from previous studies and used the datasets from GEO and TCGA databases to identify differential genes related to cuproptosis; then the data were analyzed by R package, Cytoscape, TISDB, cBioPortal, STRING, CancerSEA, and Disgenet; and finally, the data were detected by immunohistochemistry validation was performed.  \nResults CDKN2A and MTF1 were cuproptosis-associated LUAD differential genes and were differentially expressed in immune subtypes. The expression of CDKN2A and MTF1 showed correlation with multiple functional states of LUAD. CDKN2A was negatively correlated with LUAD survival prognosis.  \nConclusion CDKN2A and MTF1 were correlated with the diagnosis of LUAD, and CDKN2A was negatively correlated with the survival and prognosis of LUAD. CDKN2A has the potential to contribute to the early diagnosis and prognosis analysis of LUAD.  \nKeywords Cuproptosis, LUAD, Biological Characteristics, Bioinformatics, Immunohistochemistry  \nBackground  \nLung adenocarcinoma (LUAD) is the most common subtype of lung cancer [1], which has the highest global incidence and mortality rates, posing a significant threat to human health. Due to the lack of typical clinical manifestations in the early stages of LUAD, many patients are  \n†Meilin Li and Yu Tan contributed equally to this work.  \n*Correspondence: Lingfeng Min [minlingfeng@126.com](minlingfeng@126.com)  \n1 Xiangtan Medicine & Health Vocational College, Xiangtan, China  \n2 Northern Jiangsu People’s Hospital Affiliated to Yangzhou University, Yangzhou, China  \n3 Department of Pathology, Xiangtan Central Hospital, Xiangtan, China  \nalready metastatic at the time of diagnosis [2, 3], missing the opportunity for surgery. In recent years, with the continuous development of medical care, molecular targeted therapy and immunotherapy have become routine treatments for LUAD, improving its prognosis. However, the overall 5-year survival rate remains low. Therefore, it is of great significance to search for new and effective diagnostic and prognostic biomarkers.  \nRecently, Tsvetkov and colleagues [4] revealed for the first time a novel mechanism of cell death—cuproptosis—following pyroptosis and ferroptosis. Cuproptosis is induced by copper ions targeting lipidated  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright ","cbCaiomsmdwuFS54","https://ap.wps.com/l/cbCaiomsmdwuFS54","pdf",11529133,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Background\n# Methods","[{\"question\":\"What was the study’s main objective regarding cuproptosis in lung adenocarcinoma?\",\"answer\":\"To examine the biological characteristics and clinical significance of cuproptosis-related genes in LUAD and to understand molecular mechanisms underlying LUAD occurrence and progression.\"},{\"question\":\"Which cuproptosis-related genes were highlighted as key LUAD differential genes?\",\"answer\":\"CDKN2A and MTF1 were identified as cuproptosis-associated LUAD differential genes with distinct differential expression across immune subtypes.\"},{\"question\":\"How were the findings validated in the study?\",\"answer\":\"The study combined bioinformatics analyses using multiple databases and R/Cytoscape-related workflows, followed by immunohistochemistry validation to assess biological characteristics and clinical significance in LUAD.\"}]","Biological characterization and clinical significance of cuproptosis-related genes in lung adenocarcinoma | PDF",1790187160,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2b4c6a7d6e010bddb06807f35bd5fd1.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/011f6a30b053bde5af5c04fa83ce4ccd.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce6e48198794cec5aae342959bf1846b.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebeb413b405f546cc2b879fa089b1716.webp",980,1301]